Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT01224769
Eligibility Criteria:
Inclusion Criteria:
* patients with relapsed or refractory chronic lymphoproliferative disorders
* salvage treatment with bendamustine +/- rituximab
* age ≥ 18 years
Exclusion Criteria:
* previous treatment with bendamustine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01224769
Study Brief:
Protocol Section:
NCT01224769